New concepts in the immunopathogenesis of multiple sclerosis | Nature Reviews Neuroscience
Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis | Nature Reviews Drug Discovery
Mechanism-based criteria to improve therapeutic outcomes in progressive multiple sclerosis | Nature Reviews Neurology
Immunopathology of multiple sclerosis | Nature Reviews Immunology
Progressive multiple sclerosis: from pathophysiology to therapeutic strategies | Nature Reviews Drug Discovery
Immunopathology of multiple sclerosis | Nature Reviews Immunology
Remyelination therapies: a new direction and challenge in multiple sclerosis | Nature Reviews Drug Discovery
A molecular trio in relapse and remission in multiple sclerosis | Nature Reviews Immunology
Multiple sclerosis | Nature Reviews Disease Primers
Transcriptional analysis of targets in multiple sclerosis | Nature Reviews Immunology
Positron emission tomography in multiple sclerosis — straight to the target | Nature Reviews Neurology
Epidemiology and treatment of multiple sclerosis in elderly populations | Nature Reviews Neurology
The immunology of multiple sclerosis | Nature Reviews Immunology
Multiple sclerosis: a two-stage disease | Nature Immunology
The immunology of multiple sclerosis | Nature Reviews Immunology
Multiple sclerosis - The Lancet
Multiple sclerosis enters a grey area
Immunopathology of multiple sclerosis | Nature Reviews Immunology
Neuronal vulnerability and multilineage diversity in multiple sclerosis | Nature
Mechanism-based criteria to improve therapeutic outcomes in progressive multiple sclerosis | Nature Reviews Neurology
A lymphocyte–microglia–astrocyte axis in chronic active multiple sclerosis | Nature
Frontiers | Revisiting the Pathoetiology of Multiple Sclerosis: Has the Tail Been Wagging the Mouse?
When encephalitogenic T cells collaborate with microglia in multiple sclerosis | Nature Reviews Neurology
